• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,361
2,297
1,863
1,845
1,724

COUNTRY

872
646
269
253
211

CATEGORIES

  • 858
  • 187
  • 678
  • 1,126
    • 99
  • 389
  • 270
  • 252
  • 65
  • 378
  • 682
  • 1,319
  • 1,354
  • 625
  • 883
  • 1,690
  • 2,670
    • 574
    • 118
    • 550
    • 75
    • 526
    • 43
    • 505
    • 18
    • 18
    • 23
  • 507
  • 730
  • 0
  • 93

PRICE

6,753
11,392
17,841
25,085

PUBLISHED

1,947
2,804
7,335
25,085

PRODUCT TYPE

20,964
2,901
870
164
74
44
21
21
19
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Chronic Obstructive Pulmonary Disorder (COPD) - KOL Insight and Consensus Outlook Chronic Obstructive Pulmonary Disorder (COPD) - KOL Insight and Consensus Outlook - Product Thumbnail Image

Chronic Obstructive Pulmonary Disorder (COPD) - KOL Insight and Consensus Outlook

The prevalence of Chronic Obstructive Pulmonary Disorder (COPD) is increasing globally, its impact on the wider health economy is significant and there remains considerable unmet clinical need Valued...

October 2013
FROM

Living with Diabetes in Italy

In-depth analysis of a large online study amongst 500 patients with Type 2 diabetes, unveiling patients' attitudes, feelings, treatment programmes and needs for coping with diabetes, and includes a...

October 2013
FROM

U.S. Colony Stimulating Factors Market

In August 2012, the FDA approved Teva's tbo-filgrastim The approval was based on a full Biologic License Application (BLA) rather than under the FDA's new biosimilar approval pathway Due to a court...

October 2013
FROM

US Alzheimer Drug Pipeline Analysis

In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death While the deaths from major diseases, like heart disease...

October 2013
FROM

Infection Control for Advanced Practice Professionals

This professional reference combines research on the best practices for infection control in clinical settings with essential information for advanced practice nurses and physician assistants The book...

October 2013

Company Snapshot – Ajanta Pharma Limited

This company snapshot provides an overall assessment of the company and its progress It describes management type and share holding pattern, categories of businesses and subsidiaries, financial and...

October 2013
FROM
Company Snapshot – Glenmark Pharmaceuticals Limited Company Snapshot – Glenmark Pharmaceuticals Limited - Product Thumbnail Image

Company Snapshot – Glenmark Pharmaceuticals Limited

This company snapshot provides an overall assessment of the company and its progress It describes management type and share holding pattern, categories of businesses and subsidiaries, financial and...

October 2013
FROM

Global Oncolytic Virus Therapy Pipeline Analysis

Though still in nascent stages, Oncolytic viruses have shown immense opportunities and potential to be tapped in the future to improve the treatment of cancer and the lives of the patients Immunotherapy,...

October 2013
FROM

Orphan Drugs for Cancer Pipeline Analysis

A huge market opportunity is offered by small patient population which suffers from rare or orphan diseases Among the category of new orphan drugs, Oncology account for the largest disease group in...

October 2013
FROM
Global Hemophilia Market Report: 2013 Edition Global Hemophilia Market Report: 2013 Edition - Product Thumbnail Image

Global Hemophilia Market Report: 2013 Edition

Hemophilia is a disorder in which the blood does not clot properly, leading to extended bleeding The bleeding can be external or internal, especially in the knees, ankles, and elbows There are two types...

October 2013
FROM
Intravenous (IV) Iron Drugs - Global Strategic Business Report Intravenous (IV) Iron Drugs - Global Strategic Business Report - Product Thumbnail Image

Intravenous (IV) Iron Drugs - Global Strategic Business Report

This report analyzes the worldwide markets for Intravenous (IV) Iron Drugs in US$ Million The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin...

October 2013
FROM
Disease and Therapy Review: Obesity Disease and Therapy Review: Obesity - Product Thumbnail Image

Disease and Therapy Review: Obesity

The Obesity Disease and Therapy Review provides an overview of obesity and related conditions, with prevalence and mortality numbers, percentages and trends for major countries worldwide, and an overview...

October 2013
FROM
Disease and Therapy Review: End Stage Renal Disease Disease and Therapy Review: End Stage Renal Disease - Product Thumbnail Image

Disease and Therapy Review: End Stage Renal Disease

The End Stage Renal Disease Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence, and mortality numbers for major countries worldwide, information...

October 2013
FROM
Disease and Therapy Review: Rheumatoid Arthritis Disease and Therapy Review: Rheumatoid Arthritis - Product Thumbnail Image

Disease and Therapy Review: Rheumatoid Arthritis

The Rheumatoid Arthritis Disease and Therapy Review provides an overview of the disease and related conditions, with incidence and prevalence numbers and percentages for major countries worldwide, and...

October 2013
FROM
Disease and Therapy Review: Alzheimer's Disease Disease and Therapy Review: Alzheimer's Disease - Product Thumbnail Image

Disease and Therapy Review: Alzheimer's Disease

The Obesity Disease and Therapy Review provides an overview of obesity and related conditions, with prevalence and mortality numbers, percentages and trends for major countries worldwide, and an overview...

October 2013
FROM
Physician Views: How Do Oncologists Use Companion Diagnostics, What are the Key Challenges and Which Pharma Companies are Best at Supporting Them? Physician Views: How Do Oncologists Use Companion Diagnostics, What are the Key Challenges and Which Pharma Companies are Best at Supporting Them? - Product Thumbnail Image

Physician Views: How Do Oncologists Use Companion Diagnostics, What are the Key Challenges and Which Pharma Companies are Best at Supporting Them?

As exemplified by Roche's R&D presentation last week (see Spotlight On: Roche's R&D day – The key takeaways), the use of biomarkers to segment cancer patient populations – with the aim to both enhance...

October 2013

OTC Market in CIS Countries 2013 - Russia, Ukraine & Kazakhstan

How popular are OTC products in the CIS countries in 2013? This report compares, analyses market data and forecasts for Russia, Ukraine and Kazakhstan Over the counter drugs and a growing selection...

October 2013
FROM

Company Snapshot – Aarti Drugs Limited

This company snapshot provides an overall assessment of the company and its progress It describes management type and share holding pattern, categories of businesses and subsidiaries, financial and...

October 2013
FROM
Testosterone Replacement Therapy (TRT) - Global Strategic Business Report Testosterone Replacement Therapy (TRT) - Global Strategic Business Report - Product Thumbnail Image

Testosterone Replacement Therapy (TRT) - Global Strategic Business Report

The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World Annual estimates and forecasts are provided for the period 2010 through...

October 2013
FROM

Global Testosterone Therapy Market: Trends and Opportunities (2013-2018)

The report titled “Global Testosterone Therapy Market”: Trends & Opportunities (2013-2018)” provides an in-depth analysis of the global testosterone therapy market with detailed analysis of symptoms,...

October 2013
FROM
Loading Indicator

Our Clients

Our clients' logos